ZhouLWYuAYXNgoLHillMDFieldTS.Incidence of cerebral venous thrombosis: a population-based study, systematic review, and meta-analysis. Stroke2023; 54: 169–177.
2.
GaoLLimMNguyenD, et al. The incidence of pediatric ischemic stroke: a systematic review and meta-analysis. Int J Stroke2023; 18: 765–772.
3.
van de MunckhofABorhani-HaghighiAAaronS, et al. Cerebral venous sinus thrombosis with thrombocytopenia syndrome study group. Cerebral venous sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia in middle-income countries. Int J Stroke2023; 18: 1112–1120.
4.
CoutinhoJMvan de MunckhofAAguiar de SousaD, et al. Reducing the global burden of cerebral venous thrombosis: an international research agenda. Int J Stroke2024; 19: 599–610.
5.
FerroJMBousserMGCanhãoP, et al. European stroke organization guideline for the diagnosis and treatment of cerebral venous thrombosis—endorsed by the European academy of neurology. Eur J Neurol2017; 24: 1203–1213.
6.
MaHGuYBianT, et al. Dabigatran etexilate versus warfarin in cerebral venous thrombosis in Chinese patients (CHOICE-CVT): an open-label, randomized controlled trial. Int J Stroke2024; 19: 635–644.
7.
FerroJMBendszusMJansenO, et al. RE-SPECT CVT study group recanalization after cerebral venous thrombosis. A randomized controlled trial of the safety and efficacy of dabigatran etexilate versus dose-adjusted warfarin in patients with cerebral venous and dural sinus thrombosis. Int J Stroke2022; 17: 189–197.
8.
RiouxBToumaLNehmeAGoreGKeezerMRGioiaLC.Frequency and predictors of occult cancer in ischemic stroke: a systematic review and meta-analysis. Int J Stroke2021; 16: 12–19.
9.
Erritzøe-JervildMWenstrupJHougaardBH, et al. Diagnosing cancer-associated ischemic stroke: a systematic review of hematological biomarkers. Int J Stroke2024; 19: 622–634.
10.
NaftaliJBarneaREliahouR, et al. Lung cancer is associated with acute ongoing cerebral ischemia: a population-based study. Int J Stroke2024; 19: 406–413.
11.
ChungJWHwangJKimHJ, et al. Edoxaban for the treatment of hypercoagulability and cerebral thromboembolism associated with cancer: a randomized clinical trial of biomarker targets. Int J Stroke2024; 19: 645–653.
12.
ZhanJZhangPWenH, et al. Global prevalence estimates of poststroke fatigue: a systematic review and meta-analysis. Int J Stroke2023; 18: 1040–1050.
13.
ChuSHZhaoXKomberA, et al. Systematic review: pharmacological interventions for the treatment of post-stroke fatigue. Int J Stroke2023; 18: 1071–1083.
14.
BivardALillicrapTKrishnamurthyV, et al. MIDAS (Modafinil in Debilitating Fatigue After Stroke): a randomized, double-blind, placebo-controlled, cross-over trial. Stroke2017; 48: 1293–1298.
15.
KomberAChuSHZhaoXKomberHHalbesmaNMeadG.Non-pharmacological interventions for the treatment of post-stroke fatigue: a systematic review. Int J Stroke2023; 19: 611–621.
16.
LarssonPBidondeJOlsenU, et al. Association of post-stroke fatigue with physical activity and physical fitness: a systematic review and meta-analysis. Int J Stroke2023; 18: 1063–1070.
17.
EnglishCSimpsonDBBillingerSA, et al. A roadmap for research in post-stroke fatigue: consensus-based core recommendations from the third stroke recovery and rehabilitation roundtable. Int J Stroke2024; 19: 133–144.
18.
JollyAAZainurinAMeadG, et al. Neuroimaging correlates of post-stroke fatigue: a systematic review and meta-analysis. Int J Stroke2023; 18: 1051–1062.
19.
JollyAABrownRBTozerDJ, et al. Are central and systemic inflammation associated with fatigue in cerebral small vessel disease?Int J Stroke2024; 19: 705–713.
20.
GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the global burden of disease Study 2019. Lancet Neurol2021; 20: 795–820.
21.
ThayabaranathanTKimJCadilhacDA, et al. Global stroke statistics 2022. Int J Stroke2022; 17: 946–956.
22.
FeiginVLBraininMNorrvingB, et al. World Stroke Organization (WSO): global stroke fact sheet 2022. Int J Stroke2022; 17: 18–29.
23.
ZhangLLuHYangC.Global, regional, and national burden of stroke from 1990 to 2019: a temporal trend analysis based on the global burden of disease study 2019. Int J Stroke2024; 19: 686–694.
24.
ZhouLWeiYGeY, et al. Global, regional, and national burden of stroke attributable to extreme low temperatures, 1990-2019: a global analysis. Int J Stroke2024; 19: 676–685.
25.
GeRYouSZhengD, et al. Global, regional, and national temporal trends of diet-related ischemic stroke mortality and disability from 1990 to 2019. Int J Stroke2024; 19: 665–675.
26.
BabuVSylajaPNSomanB, et al. A randomized controlled trial of medication adherence and management of risk factors for secondary prevention of stroke (MaMoRS) using a smartphone-based application. Int J Stroke2024; 19: 654–664.
